ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
ANIFROLUMABUM
Active substance (INN) · ATC L04AG11 · 2 products authorised in Romania
1
Protocols it appears in
As a medicine of the protocol (in the title) or only mentioned in the text
| Code | Protocol | Status | Role | Sublist | GP |
|---|---|---|---|---|---|
| L04AA26-51 | LUPUS ERITEMATOS SISTEMIC - AGENŢI BIOLOGICI: BELIMUMABUM**1, ANIFROLUMABUM**1 | In force | medicine of the protocol | C1-G17 | NO |
2
Authorised brand products (ANMDM)
The Romanian register of medicines for human use, updated daily
| Brand name | Form | Strength | Holder | ATC | Rx |
|---|---|---|---|---|---|
| SAPHNELO 120 mg | SOL INJ. IN SERINGA PREUMPLUTA | 150mg/ml | ASTRAZENECA AB - SUEDIA | L04AG11 | PR |
| SAPHNELO 120 mg | SOL INJ. IN STILOU INJECTOR (PEN) PREUMPLUT | 150mg/ml | ASTRAZENECA AB - SUEDIA | L04AG11 | PR |
| SAPHNELO 300 mg | CONC. PT. SOL. PERF. | 150mg/ml | ASTRAZENECA AB - SUEDIA | L04AG11 | PR |